Tag: biosimilar
News
Sentynl Therapeutics acquires Zokinvy for treatment of Hutchinson-Gilford progeria syndrome
Sentynl Therapeutics, a US-based biopharmaceutical company wholly-owned by Zydus Lifesciences, has acquired Eiger BioPharmaceuticals' Zokinvy® (lonafarnib) program.
Zokinvy is the first and only treatment approved by...
Bayer and Evotec to develop precision treatments for cardiovascular diseases
Bayer and German-based life science company, Evotec, have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).
The...
U.S. FDA approves Neurocrine Biosciences’ INGREZZA SPRINKLE capsules
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' INGREZZA SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA (valbenazine) capsules prescribed...
